Citius Oncology, Inc. CTOR Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrentAndNoncurrent.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Citius Oncology, Inc.'s accrued expenses?
- Citius Oncology, Inc. (CTOR) reported accrued expenses of $4.06M in Q1 2026.
- How has Citius Oncology, Inc.'s accrued expenses changed year-over-year?
- Citius Oncology, Inc.'s accrued expenses decreased by 53.4% year-over-year, from $8.72M to $4.06M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.